Unibest
← Back to patent-cliff list

CAS 79-22-1

methyl carbonochloridate

Codes: ROSU-031, RIOC-012, PEME-028

Application context (from source-drug indications)

HypertensionFimasartan potassium trihydrate/Rosuvastatin calciumDyslipidaemiaFimasartan potassium trihydrate/Rosuvastatin calciumHypertensionRosuvastatin Calcium/TelmisartanHyperlipidaemiaRosuvastatin Calcium/TelmisartanPulmonary arterial hypertensionRiociguatPulmonary hypertensionRiociguatChronic thromboembolic pulmonary hypertensionRiociguatThrombosisRiociguatLeft ventricular dysfunctionRiociguatIdiopathic pulmonary arterial hypertensionRiociguatHomozygous familial hypercholesterolaemiaRosuvastatin CalciumHeterozygous familial hypercholesterolaemiaRosuvastatin CalciumHyperlipoproteinaemia type IIIRosuvastatin CalciumAtherosclerosisRosuvastatin CalciumHyperlipoproteinaemia type IIRosuvastatin CalciumHypercholesterolaemiaRosuvastatin CalciumNon-small cell lung cancerPemetrexed Disodium Hydrate间皮组织肿瘤Pemetrexed Disodium Hydrate胸膜孤立性纤维瘤Pemetrexed Disodium HydrateBladder cancerPemetrexed Disodium HydrateUrothelial carcinomaPemetrexed Disodium HydrateSolid tumourPemetrexed Disodium Hydrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Fimasartan potassium trihydrate/Rosuvastatin calciumTier C — Watch / trade-
Rosuvastatin Calcium/TelmisartanTier C — Watch / trade-
RiociguatTier B — Position early-
Rosuvastatin CalciumTier B — Position early-
Pemetrexed Disodium HydrateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.